Table 3.

Hospitalization per year and patient: Odds ratios* based on the longitudinal analysis (2011–2018).

	Intervention group versus control group (intervention effect) at the start of the study, OR (95% CI)	p-value	Control group per year (time trend), OR (95% CI)	P-value	Time trend in the intervention group versus time trend in the control group, OR (95% CI)	P-value
Elderly
Hospitalization	0.908 (0.900–0.916)	< 0.0001	0.973 (0.971–0.974)	< 0.0001	0.981 (0.979–0.983)	< 0.0001
ACSH	0.900 (0.882–0.919)	< 0.0001	0.978 (0.974–0.981)	< 0.0001	0.986 (0.981–0.990)	< 0.0001
Hospitalization for hip fracture	0.943 (0.905–0.983)	0.0055	0.984 (0.977–0.991)	< 0.0001	0.992 (0.982–1.002)	0.1046
Diabetes mellitus type 2
Hospitalization	0.949 (0.935–0.964)	< 0.0001	0.969 (0.966–0.971)	< 0.0001	0.983 (0.980–0.987)	< 0.0001
ACSH	0.943 (0.914–0.974)	0.0004	0.971 (0.966–0.976)	< 0.0001	0.984 (0.977–0.991)	< 0.0001
Diabetes-related hospitalization	0.833 (0.794–0.874)	< 0.0001	0.934 (0.926–0.942)	< 0.0001	0.996 (0.985–1.007)	0.4610
Chronic heart failure
Hospitalization	0.980 (0.960–0.999)	0.0409	0.970 (0.966–0.973)	< 0.0001	0.975 (0.971–0.979)	< 0.0001
ACSH	0.978 (0.941–1.017)	0.2638	0.987 (0.980–0.994)	0.0001	0.970 (0.961–0.978)	< 0.0001
CVD-related hospitalization	0.925 (0.901–0.949)	< 0.0001	0.962 (0.957–0.966)	< 0.0001	0.975 (0.969–0.981)	< 0.0001
Coronary heart disease
Hospitalization	0.962 (0.946–0.979)	< 0.0001	0.969 (0.966–0.972)	< 0.0001	0.983 (0.979–0.986)	< 0.0001
ACSH	0.970 (0.936–1.005)	0.0969	0.983 (0.977–0.989)	< 0.0001	0.984 (0.976–0.992)	< 0.0001
CVD-related hospitalization	0.921 (0.901–0.942)	< 0.0001	0.965 (0.961–0.969)	< 0.0001	0.978 (0.973–0.983)	< 0.0001

P-values relate to adjusted effect estimates in generalized linear models based on a longitudinal analysis from 2011 to 2018. ACSH, ambulatory, care-sensitive hospitalization.

CVD cardiovascular disease, OR odds ratio. *Odds ratios for all covariates and outcome measures are shown online in the Supplementary Table S2–13.